Cardiff Oncology
CRDF
CRDF
38 hedge funds and large institutions have $797K invested in Cardiff Oncology in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
38
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$17.6K | |
| 2 | +$4.83K | |
| 3 | +$1.04K | |
| 4 |
Bank of New York Mellon
New York
|
+$628 |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$531 |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$357K | |
| 3 | -$116K | |
| 4 |
Millennium Management
New York
|
-$70.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23K |